William Blair Issues Pessimistic Estimate for DVAX Earnings
Research analysts at William Blair reduced their Q1 2025 earnings per share estimates for Dynavax Technologies in a report ...
Le Lézard15h
Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy
Dynavax Technologies Corporation ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today issued a statement underscoring ...